Samantha F Butts1, Carter Owen2, Monica Mainigi2, Suneeta Senapati2, David B Seifer3, Anuja Dokras2. 1. Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: sbutts@obgyn.upenn.edu. 2. Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York; New York University School of Medicine, New York, New York.
Abstract
OBJECTIVE: To investigate the impact of intracytoplasmic sperm injection (ICSI) and assisted hatching (AH) on assisted reproductive technology (ART) outcomes in initial cycles with diminished ovarian reserve (DOR) as the primary diagnosis. DESIGN: Retrospective cohort study of cycles from the Society for Assisted Reproductive Technology (SART) Clinic Outcome Reporting System database. SETTING: Not applicable. PATIENT(S): A total of 422,949 fresh, nondonor, initial ART cycles of which 8,597 were diagnosed with only elevated FSH and 38,926 were diagnosed with only DOR according to the SART DOR categorization. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Live birth and clinical pregnancy rates. RESULT(S): ICSI and AH were associated with diminished odds of live birth in SART DOR-only cycles (adjusted odds ratio [AOR] 0.88, 95% confidence interval [CI] 0.81-0.96 for ICSI; AOR 0.77, 95% CI 0.71-0.84 for AH). No association between odds of live birth and either ICSI or AH in elevated FSH-only cycles was observed. The combination of ICSI and AH was associated with significantly lower odds of live birth in SART DOR-only cycles but not in elevated FSH-only cycles. CONCLUSION(S): In initial ART cycles for which the only indication relates to a diagnosis of DOR, AH and ICSI are not associated with improved live birth rates.
OBJECTIVE: To investigate the impact of intracytoplasmic sperm injection (ICSI) and assisted hatching (AH) on assisted reproductive technology (ART) outcomes in initial cycles with diminished ovarian reserve (DOR) as the primary diagnosis. DESIGN: Retrospective cohort study of cycles from the Society for Assisted Reproductive Technology (SART) Clinic Outcome Reporting System database. SETTING: Not applicable. PATIENT(S): A total of 422,949 fresh, nondonor, initial ART cycles of which 8,597 were diagnosed with only elevated FSH and 38,926 were diagnosed with only DOR according to the SART DOR categorization. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Live birth and clinical pregnancy rates. RESULT(S): ICSI and AH were associated with diminished odds of live birth in SART DOR-only cycles (adjusted odds ratio [AOR] 0.88, 95% confidence interval [CI] 0.81-0.96 for ICSI; AOR 0.77, 95% CI 0.71-0.84 for AH). No association between odds of live birth and either ICSI or AH in elevated FSH-only cycles was observed. The combination of ICSI and AH was associated with significantly lower odds of live birth in SART DOR-only cycles but not in elevated FSH-only cycles. CONCLUSION(S): In initial ART cycles for which the only indication relates to a diagnosis of DOR, AH and ICSI are not associated with improved live birth rates.
Authors: S Bhattacharya; M P Hamilton; M Shaaban; Y Khalaf; M Seddler; T Ghobara; P Braude; R Kennedy; A Rutherford; G Hartshorne; A Templeton Journal: Lancet Date: 2001-06-30 Impact factor: 79.321
Authors: Kate Devine; Sunni L Mumford; Mae Wu; Alan H DeCherney; Micah J Hill; Anthony Propst Journal: Fertil Steril Date: 2015-06-11 Impact factor: 7.329
Authors: Elena Ruggeri; Keith F DeLuca; Cesare Galli; Giovanna Lazzari; Jennifer G DeLuca; Elaine M Carnevale Journal: Reprod Fertil Dev Date: 2015-07 Impact factor: 2.311
Authors: Jennifer F Knudtson; Courtney M Failor; Jonathan A Gelfond; Martin W Goros; Tiencheng Arthur Chang; Robert S Schenken; Randal D Robinson Journal: Fertil Steril Date: 2017-08-30 Impact factor: 7.329
Authors: Axel Fun; Thomas Leitner; Linos Vandekerckhove; Martin Däumer; Alexander Thielen; Bernd Buchholz; Andy I M Hoepelman; Elizabeth H Gisolf; Pauline J Schipper; Annemarie M J Wensing; Monique Nijhuis Journal: Retrovirology Date: 2018-01-05 Impact factor: 4.602